clickhaler beclometasone 250 mikrog/annos inhalaatiojauhe
innovata biomed ltd - beclometasoni dipropionas - inhalaatiojauhe - 250 mikrog/annos - beklometasoni
innovair 100 / 6 mikrog / annos inhalaatiosumute, liuos
chiesi farmaceutici s.p.a - beclometasone dipropionate, formoterol fumarate dihydrate - inhalaatiosumute, liuos - 100 / 6 mikrog / annos - formoteroli ja beklometasoni
aerobec 50 mikrog/annos inhalaatiosumute, liuos
teva sweden ab - beclometasone dipropionate - inhalaatiosumute, liuos - 50 mikrog/annos - beklometasoni
aerobec 100 mikrog/annos inhalaatiosumute, liuos
teva sweden ab - beclometasone dipropionate - inhalaatiosumute, liuos - 100 mikrog/annos - beklometasoni
aerobec autohaler 50 mikrog/annos inhalaatiosumute, liuos
teva sweden ab - beclometasone dipropionate - inhalaatiosumute, liuos - 50 mikrog/annos - beklometasoni
aerobec autohaler 100 mikrog/annos inhalaatiosumute, liuos
teva sweden ab - beclometasone dipropionate - inhalaatiosumute, liuos - 100 mikrog/annos - beklometasoni
beclonasal forte aqua 100 mikrog/annos nenäsumute, suspensio
orion corporation - beclometasone dipropionate - nenäsumute, suspensio - 100 mikrog/annos - beklometasoni
beclonasal aqua 50 mikrog/annos nenäsumute, suspensio
orion corporation - beclometasone dipropionate - nenäsumute, suspensio - 50 mikrog/annos - beklometasoni
trimbow
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoteroli fumarate dihydraatti, glykopyrroniumbromidi - keuhkosairaus, krooninen obstruktiivinen - obstruktiivisten hengitystiesairauksien lääkkeet, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.
trydonis
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoteroli fumarate dihydraatti, glykopyrronium, - keuhkosairaus, krooninen obstruktiivinen - obstruktiivisten hengitystiesairauksien lääkkeet, - huolto hoitoon aikuisilla on keskivaikea tai vaikea krooninen keuhkoahtaumatauti (copd), jotka eivät ole riittävästi käsitelty inhaloitavaa kortikosteroidia ja pitkävaikutteinen beeta2-agonisti (vaikutukset oireita valvonta ja ehkäisy pahenemisvaiheita ks. kohta 5.